Sucampo Pharmaceuticals, Inc. (SCMP)

[tedkov]

Sucampo Shareholders Upset Over Merger Bid - (via NewsPoints Desk)
December 28, 2017
Tags: NewsPoints Sucampo Mallinkrodt United States Corporate Affairs Mergers & Acquisitions

A group of Sucampo Pharmaceuticals Inc. shareholders are attempting
to block the $1.2 billion purchase of the company by Mallinkrodt plc.

The shareholders allege that the purchase price $18 per share is insufficient in light of the company's growth
prospects and that deal-protection clauses in the merger agreement preclude other companies from submitting successful competing offers. In addition, shareholders allege that senior management obtained personal benefits for their own self interests
in agreeing to sell the company that are not being shared with common stockholders.

Sucampo did not immediately respond to requests for a comment.
To contact the law firm on behalf of shareholders of
Sucampo for more information as to how you can participate
with shareholders to get a higher price at no cost or expense
call toll free 800.511.7037 or [e-mail]